Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Assess tax efficiency between S&P 500 ETFs and index funds for retirement, focusing on taxes, distributions, and long-term strategy.
28,172 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Investors chase international dividend income, but IDV's 6-7% yield sits beside volatile cycles in oil, banks, and mi...
DoorDash has shown impressive revenue gains, but a rising price tag isn’t a guarantee of long-term value. This guide ...
A lithium-extraction startup says its new method triples recovery while shortening timelines, accelerating toward com...
As 2026 begins, homebuilders contend with thinner margins, stubborn demand, and growing war-risk headwinds, forcing l...
SpaceX's Starlink is no longer just a satellite internet service. As Oppenheimer analysts suggest, it could upend a $...
A hypothetical summer of mega-deals could redefine streaming. This article explains what Netflix should consider if F...
Two powerhouse energy stocks could shape the next decade. This guide explains why NextEra Energy and GE Vernova fit a...
LNG demand is primed to rise dramatically as the world leans on cleaner fuels. This guide highlights why the trend ma...
Alphabet shifted gears, stepping away from a $346B AI bet to chase faster AI-driven wins. Here’s what that means for ...
As the week nears its end, Thursday often brings a fresh wave of data and earnings that can move markets. This guide ...
A prominent Canadian investment firm has disclosed a new stake in Boyd Group Services, highlighting growing interest ...